Even after decades of research, there is no cure for the disease HIV causes, AIDS. But lenacapavir, born out of research on ...

While investigating how the medicine uses the body’s immune system to ward off HIV symptoms, researchers realized that it ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

UVA scientists are calling for clinical trials to see if common HIV drugs could prevent up to 1 million new Alzheimer’s cases ...

Long-acting injectable antiretroviral therapy (ART) can be administered at home to persons living with HIV as safely and ...

In a nutshell Drugs commonly used to treat HIV and hepatitis B (called NRTIs) were found to reduce the risk of developing ...

A panelist discusses how a new drug combination of doravirine and islatravir was compared to a standard bictegravir-based ...

It may result from several classes of HIV drugs, including NRTIs, NNRTIs, and PIs. Liver damage may include inflammation, death of liver cells, or too much fat in the liver. Treatment of liver ...

People taking drugs for HIV and hepatitis B are less likely to develop Alzheimer’s disease, according to a new study. UVA ...

University of Virginia (UVA) scientists are set to pursue randomised clinical trials to examine the potential for a class of ...

Exclusive: World Health Organisation says shortage of most commonly used Aids drug caused by withdrawal of US foreign aid ...

Still, you might need a secondary form of protection if you typically use hormonal methods like shots, implants, or pills ... you can start treatment to bring and keep HIV at undetectable levels.